Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.21.1
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Segment Reporting Information [Line Items]      
Revenues $ 51,805 $ 30,426  
Gross profit 29,721 15,452  
Depreciation and amortization 7,374 6,414  
Asset impairments and write-downs 259 200,043  
Purchase of property, plant and equipment 4,752 10,030  
Purchase of intangibles   292  
Assets 364,881   $ 353,133
Eastern Region      
Segment Reporting Information [Line Items]      
Revenues 33,056 18,049  
Gross profit 21,162 10,761  
Depreciation and amortization 6,178 5,519  
Asset impairments and write-downs 259 196,844  
Purchase of property, plant and equipment 4,745 9,621  
Purchase of intangibles   218  
Assets 230,195   227,237
Western Region      
Segment Reporting Information [Line Items]      
Revenues 18,302 11,725  
Gross profit 8,580 4,761  
Depreciation and amortization 838 590  
Asset impairments and write-downs   252  
Purchase of property, plant and equipment 3 388  
Purchase of intangibles   74  
Assets 109,356   109,039
Other      
Segment Reporting Information [Line Items]      
Revenues [1] 447 652  
Gross profit (21) (70)  
Depreciation and amortization 358 305  
Asset impairments and write-downs   2,947  
Purchase of property, plant and equipment 4 $ 21  
Assets $ 25,330   $ 16,857
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments and nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments.